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Breast cancer is the most common cancer in women. Primary treatment is surgery, with mastectomy as the main treatment for
most of the twentieth century. However, over that time, the extent of the procedure varied, and less extensive mastectomies are
employed today compared to those used in the past, as excessively mutilating procedures did not improve survival. Today, many
women receive breast-conserving surgery, usually with radiotherapy to the residual breast, instead of mastectomy, as it has been
shown to be as eﬀective as mastectomy in early disease. The relatively new skin-sparing mastectomy, often with immediate breast
reconstruction, improves aesthetic outcomes and is oncologicallysafe. Nipple-sparing mastectomy is newer and used increasingly,
with better acceptance by patients, and again appears to be oncologically safe. Breast reconstruction is an important adjunct to
mastectomy, as it has a positive psychological impact on the patient, contributing to improved quality of life.
1.Introduction
Escharotic materials and cautery were the main treatments
for breast cancer for hundreds years. Various simple mas-
tectomy procedures were introduced during the nineteenth
century, but none was able to cure the disease or achieve
adequate disease control [1].
2.RadicalMastectomy
The modern era of surgical treatment for primary breast
cancer began in the 1890s with the introduction of radical
mastectomy by Halsted and Meyer. William Stewart Halsted
reported his work brieﬂy in 1890 and published his more
extensive experience of patients treated at Johns Hopkins
Hospital, Baltimore, in November 1894 [2]. Willy Meyer
published his experience of New York patients in December
1894[3].SomeofHalstedandMeyer’spatientswere curedof
their disease, so for the ﬁrst time, physicians had an eﬀective
treatment for breast cancer, and radical mastectomy quickly
became the standard of care for the disease.
2.1. The Halsted-Meyer Theory. Radical mastectomy was
based on the idea that at ﬁrst, breast cancer spread only
locally or “centrifugally” by ﬁrst invading contiguous tissue
and then spreading though lymph ducts to close-by lymph
nodes, where the cells were “trapped” for some time.
Haematic spread of tumour cells—giving rise to distant
metastases—was considered to occur at a later stage.
2.2. Features of Radical Mastectomy. Radical mastectomy
involves the removal of all breast tissue, overlying skin, and
both pectoralis muscles, together with complete en bloc
removal of the axillary lymph nodes. Skin was removed
because the disease often involved the skin; in fact, the skin
was often ulcerated on presentation [2, 4]. The pectoralis
muscles were removed not simply because the chest wall
was often involved, but because it was considered essential2 International Journal of Surgical Oncology
to remove the transpectoral lymphatic pathways that run
directly through the pectoralis major to Rotter’s nodes
between the pectoralis major and pectoralis minor. At that
time, it was also considered anatomically impossible to do a
complete axillary dissection without removing the pectoralis
muscles [2, 3].
Halsted achieved a three-year local recurrence rate of
3% and locoregional recurrence rate of 20% with no
perioperative mortality. Five-year survival was 40%—twice
that of untreated patients [2]. However, morbidity after the
operation was great, because the large wounds were left to
heal by granulation, lymphedema was near universal, and
arm movement was severely restricted (due to pectoralis
muscle removal and damage to axilla nerves). For these
reasons, chronic pain was also an important sequela. Over
a century ago, surgeons were faced with large breast cancers
thatseemedtorequiredrastic treatment tohavesome chance
of cure: patients’ quality of life was not a consideration [4–
10].
Nevertheless, thanks to Halsted and Meyer, at last, it
became possible to cure breast cancer in some cases, and
systematic knowledge of the disease began to accumulate,
standardized treatments started being applied, and con-
trolled long-term studies would eventually be conducted.
It also became apparent that some women with advanced
disease did not beneﬁt from surgical treatment, and as
the twentieth century advanced, the concepts of operability
and inoperability were developed, largely by Haagensen and
Stout [11].
From1930onward,orthovoltageradiotherapywasadded
to mastectomy in many treatment centers although the
radiation dose and size and location of treatment ﬁelds
varied considerably [12–14].
2.3. Extended Radical Mastectomies. According to the
Halsted-Meyertheorythemostimportantpathwayforbreast
cancer dissemination was through the lymphatic ducts.
The implication was that chances of cure were increased
by performing wider (and ever more mutilating) surgical
resections that removed more lymph nodes [15]. From 1920
onwards, Samson Handley employed an “extended” radical
mastectomy that includedremoval ofthe lymph nodesof the
internal mammary chain. He also implanted radium needles
into the anterior intercostal spaces in order to treat internal
mammary nodes. Richard Handley, Samson Handley’s son,
studied internal mammary chain nodal involvement in
breast cancer, demonstrating that 33% of 150 breast cancer
patients had internal mammary chain involvement at the
time of surgery [16]. Andbeassen et al. [17]i nD e n m a r ka n d
Margottini [18] in Italy performed extrapleural dissection
of the internal mammary nodes [19], while Wangensteen
[20] in the USA performed supraclavicular and internal
mammary node dissection through a sternal approach.
Urban [21], at the Memorial Sloan-Kettering Hospital of
New York, performed a massive 4-5 hour operation that
combined radical mastectomy with resection of the internal
mammary chain en blocwith costalcartilages and intercostal
muscles; defects were made good with a fascia lata graft.
3.ReducedMastectomies
3.1. The Patey-Dyson Mastectomy. The centrifugal spread
idea held sway throughout the ﬁrst half of the 20th century,
and progress in breast cancer treatment was considered,
at least by some [22], to depend on even more radical
ablations. But perhaps the ﬁrst indication that extended
radical mastectomies were not necessary came from a study
by Gray [23] published in 1940, which showed that the
dermis was rich in lymphatic vessels and likely to be a plane
of ready cancer spread, while the fascia underlying the breast
was practically devoid of lymphatic vessels, which for this
reason was unlikely to be a major plane of cancer spread.
These ﬁndings encouraged some surgeons to remove more
skin; however, Patey and Dyson [24] experimented with a
reduced mastectomy that preserved the pectoralis major: in
their 1948 paper, they reviewed mastectomies performed
between 1930 and 1943, comparing their operation (which
spared the pectoralis major) with the standard radical
mastectomy. They found no diﬀerence in survival or local
recurrence rates between the two groups. Patey wrote “Until
an eﬃcient general agent for the treatment of carcinoma
of the breast is developed, a high proportion of cases are
doomed to die of the disease whatever combination of local
treatment by surgery and irradiation is used, because in such
a high proportion of cases the disease has passed outside
the ﬁeld of local attack when the patient ﬁrst comes for
treatment.”
3.2. The Madden-Auchincloss Mastectomy. In 1972, Madden
and colleagues [25] presented results of a consecutive series
of patients treated by their “modiﬁed” radical mastectomy,
in which both the pectoralis major and the pectoralis minor
were preserved. Outcomes were similar to those using the
radical mastectomy. Patey argued that complete axillary
dissection was not possible if the pectoralis minor was
preserved.Itwasalsoarguedthatthepectoralisminor’snerve
and blood supply were not conserved, leaving the muscle
useless [24].
However, Madden’s lymphangiographic data showed it
was possible to clear the axilla. It was also possible to
preserve the neurovascular supply to the pectoralis minor
muscle [25]. Auchincloss [26] also presented data in favour
of the modiﬁed radical mastectomy that conserved the
pectoralis minor. Auchincloss also questioned the need to
perform complete axillary dissection, suggesting that the
apical nodes (Berg level III—[27]) should only be removed
when evidently invaded.
Crile [28] went further and suggested that axillary dis-
section should not be performed immediately if the axilla
was not evidently involved, at least in patients with stage I
breast cancer, but only subsequently if axillary involvement
developed. Survival rates following delayed axillary dissec-
tion were equal to or better than following prophylactic
lymph node dissection [28].
Anotherobjectiontopreservationofthepectoralisminor
was that the interpectoral lymphatic (Rotter) nodes could
be a source of disease recurrence. However, recurrence atInternational Journal of Surgical Oncology 3
this site is unusual, and even if it occurs, muscle invasion is
uncommon.
3.3. Simple Mastectomy. The simple mastectomy was ﬁrst
developed by Kennedy and Miller [29], based on indications
that radical mastectomy was not always necessary in women
with breast cancer. Simple mastectomy is a fairly rapid
operation in which the pectoral fascia is removed in bloc
with the breast, but neither the pectoralis muscles nor the
axillary lymph nodes are removed. Kaae and Johansen [30]
compared simple mastectomy plus postoperative radiother-
apy with extendedradical mastectomy plusradiotherapy and
found that overall survival rates were similar in both.
4.Breast Conservationas
anAlternativeto Mastectomy
The controversy between extended and reduced mastec-
tomies crystallized in the 1970s when Bernard Fisher mar-
shalled evidence that breast cancer was a systemic disease
from the outset and that distant metastases were present
well before diagnosis in most cases. The implication was
that extended mastectomies were useless. However, Fisher
also cited evidence that debulking the tumor mass might
stimulate the body to destroy remnant tumor cells by
immunologic and other mechanisms, perhaps in combi-
nation with systemic cytotoxic agents [31]. These ideas
stimulated surgeons to experiment with breast-conserving
treatments for breast cancer, variably combined with elective
axillary dissection, radiotherapy to the residual breast, and
chemotherapy. The ﬁrst major clinical trials investigating
breast conservation began in the 1970s, in coincidence with
more widespread use of mammography to identify small
lesions and permit diagnosis of breast cancer at an earlier
stage. The ﬁrst to trial to publish ﬁve-year results was that
of Veronesi’s group in Milan [32]. This trial compared
quadrantectomy plus radiotherapy plus axillary dissection
with radical mastectomy and found no diﬀerence between
thetwotreatments. Subsequently,Fisheret al.[33] published
ﬁve-year results of their trial comparing lumpectomy with
“total mastectomy” that removed the entire breast, pectoral
fascia, and axillary contents en bloc. Twenty-year follow-
up of both these landmark studies [34, 35]c o n ﬁ r m e dt h a t
conservative breast surgery is equivalent to mastectomy
as a treatment for breast cancer. This was an important
advance, as the mutilation that went with mastectomy was
considerably reduced by the conservative approach.
5.New Mastectomies
Today the standard of care for patients with stage I/II breast
cancer is lumpectomy or a more extended resection like
quadrantectomy, followed by whole breast irradiation [34–
36]. However, for more advanced disease, and a number
of other indications, such as inﬂammatory breast cancer,
intraepithelial neoplasia not amenable to breast-conserving
surgery, or local recurrence after breast conserving surgery,
mastectomy is necessary. At the same time, the mastectomy
operation continues to undergo modiﬁcation as part of the
shift to less extensive but oncologically adequate procedures
that are more technically demanding than the traditional
mastectomy procedures.
5.1. Skin-Sparing Mastectomy. Mastectomy with skin preser-
vation was ﬁrst applied by Freeman to two patients with
benign breast disease [37]. Toth and Lappert [38]w e r e
the ﬁrst to report a skin-preserving mastectomy for breast
cancer that required considerable preoperative planning
of the incisions in order to maximize skin preservation,
and therebyfacilitate breastreconstruction—whose aesthetic
outcome depends considerably on the quantity of breast
skin remaining. Their operation consisted of breast gland
removal, removal of the nipple-areola complex, biopsy
scar, and skin overlying the cancer (if superﬁcial) with
preservation of remaining skin and inframammary fold.
The beneﬁts of skin-sparing mastectomy are that it
reduces postmastectomy deformity, allows better breast
shape after reconstruction, minimizes residual scarring, and
reduces the area of skin necessary on myocutaneous ﬂaps.
It also reduces the need for contralateral breast surgery to
achieve symmetry [39].
Doubts remain about oncological safety of skin-sparing
mastectomy, particularly since randomized controlled stud-
ies have not been conducted, and residual breast tissue
often remains in the skin envelope [40–42]. However,
even in cases undergoing conventional mastectomy, residual
breast tissue is present on the skin ﬂaps (excluding nipple-
areola complex) in around 23% of cases [43]. Furthermore,
retrospective studies with followup ranging from 35 to 70
months suggest no diﬀerences in recurrence or survival
rates between patients undergoing skin-sparing mastectomy
with reconstruction and those undergoing conventional
mastectomy [44–51].
The most common complications of skin-sparing mas-
tectomy are skin necrosis, infection, and hematoma [52–58].
Infectionandhematomaoccursin2%–19%ofcases[52–57].
Skin ﬂap necrosis occurs in about 11% of cases when there
are no risk factors [52]. Similar rates ofnecrosis are observed
after modiﬁed radical mastectomy [52]. Smoking is a major
risk factor for necrosis [52]. Other factors that increase the
risk of necrosis are previous breast irradiation, diabetes,
and high body mass index [52]. These complications do
not usually delay the administration of adjuvant therapies
[59–61]. Reduced skin sensitivity occurs in around 65% of
patients [62].
Indications for skin-sparing mastectomy are BRCA1/2
mutation, intraepithelial neoplasia (DIN or LIN), particu-
larly when the lesion is extensive, multicentric or recurrent,
and early-stage breast cancer for which breast-conserving
therapy is not suitable [63]. Some of studies support
the use of skin-sparing mastectomy following neoadjuvant
treatment, for recurrence after breast-conserving surgery,
and malignancy after additive mammoplasty [64–66].
Skin involvement by the tumour is an absolute con-
traindication for skin-sparing mastectomy. Relative con-
traindications are adjuvant radiotherapy, smoking, previous4 International Journal of Surgical Oncology
irradiation, high body mass index, and delayed reconstruc-
tion [52, 67–71].
5.2.Nipple-Sparing Mastectomy. Nipple-sparingmastectomy
is a reﬁnement of skin-sparing mastectomy in which the
nipple-areolar complex is spared. Once again, its aim is to
improve the aesthetic outcome of the reconstruction, which
is usually performed immediately [72]. Nipple sparing mas-
tectomy can be associated with intraoperative radiotherapy
to the nipple-areolar complex [72, 73]. One intraoperative
irradiation technique (ELIOT) employs electrons at a dose
of 16Gy directly to the nipple-areolar complex. A combined
aluminium and lead disc is placed under the complex and
over the chest to protect the chest wall [73].
Contraindications for nipple-sparing mastectomy are
centralquadranttumours,clinicalevidenceofnipple-areolar
complex involvement, bloody nipple discharge, palpable
tumours less than 1cm from the nipple, and micro-
calciﬁcationsorotherradiologicalalterationsnearthe nipple
[74]. Frozen retroareolar tissue is examined intraoperatively
and if positive for malignancy nipple sparing is not per-
formed [72–74].
Petit et al. [73] reported on 289 patients who underwent
nipple-sparing mastectomy with intraoperative radiotherapy
(ELIOT) to the nipple-areolar complex. Three percent of
their patients had total necrosis of the nipple-areolar com-
plex, an additional 9.5% had partial necrosis, and the entire
complexhad toberemovedin 4.6%.After1yearoffollowup,
cosmetic outcomeswere rated goodby 82.3%ofpatientsand
by 84.8% of surgeons. Radio dystrophy occurred in 7.5%.
Nipple-areolarcomplexsensitivity returnedpartially in 48%.
No local recurrence occurred beneath the preserved nipple-
areolar complex although followup was short [73].
As with skin-sparing mastectomy, there is concern that
retaining the nipple-areolar complex increases the likelihood
of disease recurrence; however, the available experience
suggests that this is not the case [72–76]. To achieve opti-
mal cosmetic results with oncologic safety, nipple-sparing
mastectomy should be performed on only carefully selected
patients [74, 75].
5.3. Prophylactic Risk-Reduction Mastectomy. Five-to-ten
percent of breast cancers occur in women with a deleteri-
ous mutation in BRCA1, BRCA2, or other breast cancer-
associated genes [77, 78]. BRCA1 and BRCA2 mutations
are quite penetrating: the cumulative risk of breast cancer
is about 65% in BRCA1-mutation carriers (by age 70)
and about 45% in BRCA2-mutation carriers [79, 80].
Mastectomy has long been proposed as a means of avoiding
breast cancer in women with BRCA1 and BRCA2 mutations.
Meijers-Heilboeretal. studiedtheoncologicalresultsofrisk-
reduction mastectomy in 139 persons with these mutations,
randomizing them to breast cancer screening or reducing
risk mastectomy [81]. After an average followup of 3.0 years,
breast cancers occurred in 8 screening group women but in
none of the mastectomy group [81]. However, mastectomy
does not completely eliminate the risk of breast cancer [82–
84]. Deleterious mutation carriers considering prophylactic
mastectomy should be evaluated by a multidisciplinary team
consisting of geneticist, oncologist, breast surgeon, plastic
surgeon, and psychologist [85, 86].
6.ReconstructiveSurgeryafterMastectomy
Options for breast reconstruction after mastectomy con-
sist of autologous transplants, implants, and combinations
of both. Autologous breast reconstruction employs both
pedicle-basedandfree ﬂaps. Localpedicleﬂapsarelatissimus
dorsi ﬂaps and transverse rectus abdominis myocutaneous
(TRAM) ﬂaps. Free ﬂaps include the deep inferior epigastric
perforator (DIEP), free TRAM ﬂaps, and gluteal artery
perforator (GAP) ﬂaps.
The latissimus dorsi ﬂap was introduced by Schneiders
in 1977 and produces satisfactory aesthetic results [87].
Endoscopy can be used to mobilize latissimus dorsi ﬂaps
and minimize dorsal scarring. This ﬂap can also be used in
association with implants to improve cosmetic results [39].
The DIEP ﬂap, originally proposed by Holmstrom in
1979, makes large-volume transfer possible, with preser-
vation of the abdominal muscles and aponeurotic layers,
[88] and reduces complications such as muscular weakness,
bulging and hernia; however, the operating time is longer
than for other breast reconstructions.
The TRAM ﬂap was introduced by Hartrampf et al. in
1982 [89]. Patients report high levels of aesthetic satisfaction
with this technique [90]. However, donor site complications
occurmorefrequentlythanwith DIEPﬂap.The freesuperior
gluteal artery perforator (S-GAP) ﬂap was ﬁrst used for
breast reconstruction in 1995 [91]. It allows transfer of skin
and fat without sacriﬁcing the gluteus maximus.
Several types of expanders and prostheses are used
for breast reconstruction. The introduction of anatomically
proﬁled implants improved this type of reconstruction so
that good breast volume, shape, and symmetry are routinely
achieved with low complication rates [39, 92, 93].
The choice of breast reconstruction technique depends
on the anatomical characteristics of the patient and the
skill and experience of the plastic surgeon. The risk of
reconstruction failure is higher in smokers, obese patients
and, those with large breast [39, 52, 71].
7.Conclusions
Mastectomy has evolved from the frankly mutilating but
often eﬀective Halsted radical mastectomy to the tech-
nically more demanding skin-sparing and nipple-sparing
approaches that are increasingly used today. These new
mastectomies provide results that are oncologically equiva-
lent to the older operations but make it easier to perform
immediate breast reconstructions thatachievegood aesthetic
resultsandreducepsychologicalmorbidity.Atthesametime,
mastectomy has been supplanted by surgical approaches that
conserve the breast for a large fraction of breast cancer
patients in Western countries, in part because breast cancer
is diagnosed at a much earlier stage. There is no sign yet that
surgery for breast cancer will be supplanted by noninvasiveInternational Journal of Surgical Oncology 5
treatments, so the way forward seems to be the development
of increasingly sophisticated and demanding surgical proce-
dures that are ever more precisely tailored to the individual
patient and typically require the skills of a plastic surgeon
as well as the breast surgeon and multidisciplinary team. It
seems important to develop ways of reducing the failure and
complication rates for the breast reconstruction procedures
facilitated by the new mastectomies.
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